Drugs

Tech

Chinese biotech sector is blowing hot as M&A and IPO deals surge amid Covid-19 pandemic

China’s biotechnology merger and acquisition (M&A) transactions have almost doubled this year, with interest perking up among investors amid a…

Read More »
Tech

Baidu, investors said to be in talks to raise US$2 billion for biotech start-up using AI technology

Chinese tech giant Baidu is in talks with investors to raise up to US$2 billion over three years for a…

Read More »
Tech

GeneHarbor plans Hong Kong IPO to fund new medicinal products, widen anti-ageing supplements line

The dietary supplement producer, established in 2004, spent 2 billion yuan (US$294 million) to build a factory this year in…

Read More »
Tech

Billionaire Li Ka-shing’s biotech unit hopes for new cancer drug approvals, expands sales army in China amid stock rally in London

Hutchison China MediTech (Chi-Med), whose stock has surged 70 per cent in London over the past six months, expects to…

Read More »
Tech

Hong Kong scientist behind artificial ‘mini-hearts’ takes Novoheart closer to China with facilities to quicken drug discovery process

Novoheart Holdings, the inventor of artificial “mini-hearts” co-founded by a Hong Kong scientist, is expanding its research and manufacturing budget…

Read More »
Tech

New Discovery Could Reduce the Side Effects of Ozempic and Wegovy

A new study has pinpointed brain neurons that separate the sensation of fullness from nausea in obesity drugs, paving the…

Read More »
Tech

Safer New MDMA “Ecstasy” Variants Discovered

Research on MDMA’s use in psychotherapy have led to new variants developed by MedUni Vienna that could offer similar benefits…

Read More »
Tech

Far-Reaching Implications – Scientists Discover Previously Hidden Binding Sites for Medications

Researchers have found that studying proteins at body temperature reveals new drug binding sites, potentially revolutionizing drug design by providing…

Read More »
Tech

Key to Improving Cancer Treatments Discovered

Ubiquitin plays a crucial role in cellular processes by regulating protein stability, but USP28 inhibitors, aimed at inhibiting cancer growth,…

Read More »
Tech

Existing Cancer Drug Alleviates Rare Genetic Syndrome

A recent study shows that ruxolitinib, a drug targeting interferon-gamma (IFN-gamma), effectively alleviates symptoms of the rare autoimmune polyendocrine syndrome…

Read More »
Back to top button